VENROCK PARTNERS V L P

CIK 1395760 · last filed 2020-11-18

VENROCK PARTNERS V L P is a corporate insider who has filed 5 SEC Form 4 insider transactions across 4 companies since 2012. The most recent filing, for NET, was dated Nov 18, 2020. Across all open-market trades the lifetime net is +$1.7M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $7.43B across reported positions. The firm reports its address in Palo Alto, CA. 38 SEC filings were submitted jointly with VENROCK ASSOCIATES V LP.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$7.43B

Companies

4

Total Filings

5

Lifetime Open-Market Net

$1.70M

Filer Profile

Reported Address

3340 HILLVIEW AVENUE
PALO ALTO, CA 94304

Phone

(650) 475-3771

Related Filers

VENROCK ASSOCIATES V LP — 38 joint filings, latest 2022-02-18

Venrock Management V, LLC — 38 joint filings, latest 2022-02-18

Venrock Partners Management V, LLC — 38 joint filings, latest 2022-02-18

VEF Management V, LLC — 33 joint filings, latest 2022-02-18

Venrock Entrepreneurs Fund V, L.P. — 33 joint filings, latest 2022-02-18

Zeltiq Aesthetics Inc — 6 joint filings, latest 2014-01-27

BRYAN E ROBERTS — 4 joint filings, latest 2012-09-24

Venrock Associates VI, L.P. — 3 joint filings, latest 2022-02-18

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
NET	10%+ Owner	21,134,616	$351.67	$7.43B	$0	2	2020-11-18
CASTLIGHT HEALTH, INC. (CSLT) Delisted	10%+ Owner	—	$2.05	—	$0	1	2014-03-19
IRWD	10%+ Owner	88,262	$4.41	$389.2K	$0	1	2013-03-19
Zeltiq Aesthetics Inc (ZLTQ) Delisted	10%+ Owner	5,323,233	—	—	$1.70M	1	2012-08-06

Recent Filings

5 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2020-11-18	NET	Other (J)	−30,000,000	$0	EDGAR
2020-03-25	NET	Conv (C)	+247,849,080	$0	EDGAR
2014-03-19	CASTLIGHT HEALTH, INC. (CSLT) Delisted	Conv (C)	—	$0	EDGAR
2013-03-19	IRWD	Other (J)	−3,882,760	$0	EDGAR
2012-08-06	Zeltiq Aesthetics Inc (ZLTQ) Delisted	Buy (P)	+360,000	$1.70M	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.